Leukemia
Showing NaN - NaN of 315
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)
Active, not recruiting
- Leukemia
- Alemtuzumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 2, 2022
Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)
Recruiting
- Lymphoma
- +2 more
- Kappa CD28 T cells
-
Houston, Texas
- +1 more
Jan 31, 2022
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Development ofVideo Game for Improvement of Outcomes in Stem
Recruiting
- Leukemia
- Lymphoma
- Focus Group
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 19, 2021
Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Nivolumab
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 9, 2021
Leukemia, Lymphoma Trial in Houston (other, behavioral, dietary supplement)
Active, not recruiting
- Leukemia
- Lymphoma
- Counseling
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 17, 2021
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Leukemia
- Fludarabine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 11, 2021
After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
- Central Nervous System Lymphoma
- +5 more
- Magnetic Resonance Imaging
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 12, 2021
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)
Active, not recruiting
- B-Cell Non-Hodgkin Lymphoma
- +5 more
- Ipilimumab
- Lenalidomide
-
Houston, TexasM D Anderson Cancer Center
Aug 6, 2021
Leukemia, CLL Trial in Houston (Lenalidomide)
Completed
- Leukemia
- CLL
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 30, 2021
Leukemia Trial in Houston (MEK 162)
Terminated
- Leukemia
- MEK 162
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 25, 2021
Leukemia, Lymphoma Trial in Houston (HSCT, DLI)
Completed
- Leukemia
- Lymphoma
- HSCT
- DLI
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 9, 2021
Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)
Completed
- Stem Cell Transplantation
- Leukemia
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 21, 2021
Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia Trial in Houston (Busulfan, Fludarabine)
Completed
- Myelodysplastic Syndrome
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 12, 2021
Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)
Recruiting
- Leukemia
- +2 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 13, 2021
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Cognitive Training in Attenuating Attention Deficits/Child
Active, not recruiting
- Leukemia
- +2 more
- Cognitive Training Program
- Control Group
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 29, 2020
Leukemia, Lymphoma Trial in Houston (Actonel (Risedronate), Calcium, Vitamin D)
Completed
- Leukemia
- Lymphoma
- Actonel (Risedronate)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 2, 2020
Leukemia Trial in Houston (Decitabine, Azacitidine)
Completed
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 1, 2020